Skip to content

Cytokinetics Inc.

company in South San Francisco, United States

CYTK Nasdaq SEC CIK 1061983

Follow Cytokinetics Weekly email: filings, results, news

News

10 stories filed under Cytokinetics, grouped into ongoing threads

CEO robert

Thread · 3 stories

Insider Transaction: Cytokinetics CEO Robert Blum Sells 7,500 Shares for $575,700

Markets 33 d ago also on BLMH

Capricor shares spike on CEO comments; Cytokinetics sues Bristol Myers

Markets 41 d ago

Cytokinetics president & CEO Robert Blum sells $575,700 in shares

Markets 44 d ago 2 sources also on BLMH

More coverage

Cytokinetics (CYTK): Can Myqorzo Growth Create a New Biopharma Success Story?

Markets 1 d ago

Truist reiterates Buy on Cytokinetics stock, $112 target on HCM potential

Markets 23 d ago also on HCM

ESC ‘26: Cytokinetics’ sell-off, Arrowhead’s edge and a heart drug autopsy

Markets 24 d ago

Cytokinetics, Incorporated (CYTK) Discusses Positive Phase III Results From ACACIA-HCM Trial of Aficamten in Nonobstructive HCM Transcript

Markets 27 d ago also on HCM III

STAT+: Cytokinetics details trial win for what could be its next approval

Markets 27 d ago

Citizens raises Cytokinetics stock price target on strong launch

Markets 48 d ago

Cytokinetics, Incorporated (CYTK) Q2 2026 Earnings Call Transcript

Earnings 48 d ago

Next results

NOV5

FY 2026 results

Thursday · estimated from the filing cadence

Profile

Headquarters: SOUTH SAN FRANCISCO, CA, United States
Founded: 1997
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: cytokinetics.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 10 stories clustered from the RSS aggregator